Workflow
Rite Aid(RAD)
icon
Search documents
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹⁶¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
Globenewswire· 2025-06-24 12:00
Under the agreement, Cyclotek will produce and provide doses of Tb-labeled RAD 402 to support Radiopharm's upcoming Phase 1 clinical trial in prostate cancer in Australia. The Phase 1 trial is anticipated to start in the second half of 2025. RAD 402 preclinical data package complete; demonstrates safety and promising biodistribution profile Ethics approval and Phase 1 clinical trial start in prostate cancer anticipated in 2H 2025 SYDNEY and BUNDOORA, Australia, June 24, 2025 (GLOBE NEWSWIRE) -- Radiopharm T ...
Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases
Globenewswire· 2025-06-11 12:00
RAD101 in U.S. Phase 2 clinical trial to distinguish between recurrent disease and treatment effect of brain metastases originating from solid tumors of different origin SYDNEY, June 11, 2025 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD, "Radiopharm" or the "Company"), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track De ...
Rite Aid Prepares to Sell Remaining Assets
PYMNTS.com· 2025-06-10 22:27
As the June 18 deadline for bidding on the remaining assets of Rite Aid nears, the potential buyers who are looking them over reportedly include pharmacy chain Walgreens, reality star turned entrepreneur Kourtney Kardashian, consumer-focused private equity firms, and three brand management companies: Authentic Brands Group, WHP Global and Marquee Brands.By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, i ...
Kourtney Kardashian, Walgreens, more eyeing bankrupt Rite Aid's assets: report
New York Post· 2025-06-10 18:24
Core Insights - Rite Aid is undergoing bankruptcy proceedings, with various companies, including Walgreens and brand management firms, evaluating its remaining assets [1][4][9] - Kourtney Kardashian has shown interest in acquiring Rite Aid's Thrifty ice cream brand, which has a history dating back to 1940 [3][7] Group 1: Bankruptcy and Asset Evaluation - Rite Aid operates approximately 1,200 stores and serves around 8 million customers, having filed for bankruptcy for the second time in two years [4][8] - The bankruptcy judge has approved store closures and the sale of customer prescription files to 13 buyers, including CVS Health and Walgreens [4][10] - Brand management companies such as Authentic Brands Group, WHP Global, and Marquee Brands are assessing Rite Aid's intellectual property and loyalty program [1][2] Group 2: Interest in Thrifty Ice Cream Brand - Kourtney Kardashian, co-founder of Lemme and owner of Poosh, is interested in Rite Aid's Thrifty ice cream brand, which is sold at various retailers [3][5][6] - Thrifty ice cream has a notable history and has attracted interest from consumer-focused private equity firms as well [7]
Radiopharm Theranostics Doses First Patient in Phase 1 ‘HEAT’ Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid Tumors
Globenewswire· 2025-06-04 12:00
Phase 1 First-In-Human study designed to assess safety, tolerability, right dose for Phase 2 and early signs of efficacy of 177Lu-RAD202 in individuals with advanced HER2-positive solid tumors Previous clinical proof-of concept data for targeting HER-2 demonstrated the safety and biodistribution of 99mTc-RAD202 in humans SYDNEY, June 04, 2025 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD, "Radiopharm" or the "Company"), a clinical-stage biopharmaceutical company focused on developing innovative oncol ...
Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake
Globenewswire· 2025-06-02 12:00
Supports plans to advance the RV01 program to first-in-human therapeutic basket study in solid tumour cancers Data completes preclinical package for Investigational New Drug submission in mid-2025 with Phase 1 therapeutic study initiation expected in 4Q25 SYDNEY, Australia, June 02, 2025 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX: RAD, Nasdaq: RADX, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of hig ...
Rite Aid Closing Stores and Selling Pharmacy Assets to Rivals
PYMNTS.com· 2025-05-19 16:09
Rite Aid is reportedly closing additional stores while handing off business to rivals.The drugstore chain, which recently filed for bankruptcy for the second time, has revealed 95 locations it wants to shut down, Fast Company reported, citing a court filing.The locations are spread across six states, but are primarily based in Rite Aid’s home state of Pennsylvania, where the company plans to close more than 70 stores. In total, Rite Aid has targeted 210 stores for closure, the report said.The filing came on ...
药房连锁CVS Health Corp.寻求收购Rite Aid Corp.位于美国西北部的多家门店和病患数据,后者正第二次申请破产。
news flash· 2025-05-16 14:31
药房连锁CVS Health Corp.寻求收购Rite Aid Corp.位于美国西北部的多家门店和病患数据,后者正第二 次申请破产。 ...
Rite Aid To Sell Pharmacy Assets From More Than 1,000 Stores To CVS, Walgreens And Grocers
Forbes· 2025-05-15 23:05
CVS Health confirmed interest in so-called “prescription files” of Rite Aid customers from the ... More bankrupt chain’s stores in the Pacific Northwestern U.S. The bid by CVS comes after Rite Aid earlier this month said it is “pursuing a strategic and value-maximizing sale process for substantially all of its assets,” the company said on May 5, 2025. “To facilitate this process, the company and its subsidiaries commenced voluntary Chapter 11 proceedings in the U.S. Bankruptcy Court for the District of New ...
Radiopharm Theranostics to Participate in the D. Boral Capital Inaugural Global Conference
Globenewswire· 2025-05-07 12:00
For more information: Investors: Riccardo Canevari CEO & Managing Director P: +1 862 309 0293 E: rc@radiopharmtheranostics.com Radiopharm Theranostics is a clinical stage radiotherapeutics company developing a world-class platform of innovative radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. Radiopharm is listed on ASX (RAD) and on NASDAQ (RADX). The company has a pipeline of distinct and highly differentiated platform technologies spanning pepti ...